News | October 22, 2025
Cambrex to invest $120 million to expand API manufacturing in US
Expanding US operations to address the increased demand for API development and manufacturing
Expanding US operations to address the increased demand for API development and manufacturing
The initial $100 million will fund a state-of-the-art hard-shell capsule facility in Atlanta
Results from the Phase 2 PHAROS trial potentially establish new benchmark with targeted combination therapies for this patient population
Approval broadens indication for Tezspire to a second disease characterized by epithelial-driven inflammation
Triamcinolone Acetonide injectable suspension USP is indicated for various autoimmune, inflammatory, and other conditions
Zaltenibart offers best-in-class potential across multiple rare blood and kidney disorders, enhancing Novo Nordisk’s rare disease portfolio
This partnership marks a significant step in strengthening Healthium’s position in the cardiac care segment
Sourced and formulated in the United States, Ameriflor Calm is derived from plants grown on regenerative organic certified farms and is manufactured at a site that uses 100% renewable electricity
In this role, Neeraj will be responsible for crafting strategy, driving profitable growth through organic and inorganic models, expanding client base
This new suite of products demonstrates Nouryon’s leadership in cleaning ingredient solutions
Subscribe To Our Newsletter & Stay Updated
